InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.00
(
2.14%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,712.68
(
-0.28%
)
Post# of 251706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 253
Posts 17905
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: None

Thursday, 08/16/2018 3:08:07 PM

Thursday, August 16, 2018 3:08:07 PM

Post# of 251706
More news re TEVA:

https://www.wsj.com/articles/fda-approves-tevas-generic-version-of-epipen-injector-1534442412?mod=nwsrl_pro_pe_industry_news&cx_refModule=nwsrl

https://www.yahoo.com/news/fda-approves-teva-generic-epipen-182901627.html

"....Shares of Teva Pharmaceuticals were climbing on the news while Mylan shares were lower. Adamis Pharmaceuticals’ shares were lower. In July, Adamis was granted U.S. approval to sell an EpiPen rival. It will announce the pricing of the product in the second half of the year, according to Reuters...."

Will ADMP be able to compete with TEVA?

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up